Dr. Anna Rutherford is a transplant hepatologist with expertise in caring for patients with chronic liver disease and advanced liver disease, before and after liver transplantation. Her particular clinical interests include acute liver failure, advanced liver disease and liver disease in pregnancy. She spends the majority of her time caring for patients with liver disease in clinic, endoscopy, and on the inpatient service at Brigham and Women’s Hospital (BWH) and Massachusetts General Hospital (MGH).
In 2016 Dr. Rutherford was appointed the Clinical Director of Hepatology at Brigham & Women’s Hospital, which has involved building relationships with Massachusetts General Hospital and University of Massachusetts liver transplant programs and developing an inpatient hepatology service at Brigham & Women’s Hospital. She is an Assistant Professor of Medicine at Harvard Medical School.
Dr. Rutherford dedicates the balance of her time to medical education and clinical research. She is the director of the 7-week gastroenterology pathophysiology course for medical students in the Harvard-MIT Program in Health Sciences and Technology. Her clinical research has focused on identifying factors that affect clinical outcome in acute liver failure and liver transplantation, predictors of hepatic decompensation as well as liver disease and pregnancy. Dr. Rutherford is an Associate Editor for the Clinical Observations section in Hepatology, and she serves on the Medical Advisory Board for the New England chapter of the American Liver Foundation. In 2018, Dr. Rutherford was awarded the Dr. Jerry Trier Award for Excellence in Clinical Teaching (HMS) and in 2019 she was the recipient of the Irving M. London Teaching Award for excellence and dedication to teaching in biomedical science (HMS/HST).
